Leach CL - Search Results

1

A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.

Leach CL, Colice GL. Leach CL, et al. J Aerosol Med Pulm Drug Deliv. 2010 Dec;23(6):355-61. doi: 10.1089/jamp.2009.0783. Epub 2010 Jun 24. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20575669

2

Targeting inhaled steroids.

Leach C. Leach C. Int J Clin Pract Suppl. 1998 Sep;96:23-7. Int J Clin Pract Suppl. 1998. PMID: 10344030 Review.

3

Asthma management with HFA-BDP (Qvar).

Davies R, Leach C, Lipworth B, Shaw R. Davies R, et al. Hosp Med. 1999 Apr;60(4):263-70. doi: 10.12968/hosp.1999.60.4.1093. Hosp Med. 1999. PMID: 10396432

4

Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans.

Leach C. Leach C. J Allergy Clin Immunol. 1999 Dec;104(6):S250-2. doi: 10.1016/s0091-6749(99)70041-2. J Allergy Clin Immunol. 1999. PMID: 10588985

5

Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers.

Leach CL, Bethke TD, Boudreau RJ, Hasselquist BE, Drollmann A, Davidson P, Wurst W. Leach CL, et al. J Aerosol Med. 2006 Summer;19(2):117-26. doi: 10.1089/jam.2006.19.117. J Aerosol Med. 2006. PMID: 16796536

6

Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.

Leach CL, Kuehl PJ, Chand R, McDonald JD. Leach CL, et al. J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):127-33. doi: 10.1089/jamp.2014.1199. Epub 2015 Jun 10. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26061801

7

Nasal Deposition of HFA-Beclomethasone, Aqueous Fluticasone Propionate and Aqueous Mometasone Furoate in Allergic Rhinitis Patients.

Leach CL, Kuehl PJ, Chand R, McDonald JD. Leach CL, et al. J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):334-40. doi: 10.1089/jamp.2014.1180. Epub 2015 Feb 11. J Aerosol Med Pulm Drug Deliv. 2015. PMID: 25671692 Clinical Trial.

8

Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.

Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD. Leach CL, et al. Ann Allergy Asthma Immunol. 2012 Mar;108(3):195-200. doi: 10.1016/j.anai.2012.01.010. Ann Allergy Asthma Immunol. 2012. PMID: 22374204

9

Inhalation aspects of therapeutic aerosols.

Leach CL. Leach CL. Toxicol Pathol. 2007 Jan;35(1):23-6. doi: 10.1080/01926230601072335. Toxicol Pathol. 2007. PMID: 17325969 Review.

10

Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.

Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Leach CL, et al. J Aerosol Med. 2005 Winter;18(4):379-85. doi: 10.1089/jam.2005.18.379. J Aerosol Med. 2005. PMID: 16379614 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results